Orthobiologics Devices And Equipment Market Size, Application, CAGR Analysis And Future Forecast To 2033

The new report published by The Business Research Company, titled ""Orthobiologics Devices And Equipment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the orthobiologics devices and equipment market size has grown strongly in recent years. It will grow from $5.29 billion in 2023 to $5.74 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The orthobiologics devices and equipment market size is expected to see strong growth in the next few years. It will grow to $7.39 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2568&type=smp

Global Aging Population Fuels Growth In The Orthobiologics Devices And Equipment Market
The aging population profile of most countries contributed to the growth of orthobiologics devices and equipment market globally. According to the United Nations report, there were 962 million people aged over 60 across the globe, comprising 13% of the global population. The population aged over 60 is expected to grow at a rate of about 3% every year. The report further estimated that Europe had the highest percentage of the population aged over 60. The number of people globally over the age of 65 grew by 33%, according to estimates based on Population Reference Bureau data. The increase in the aging population has increased the patient pool of many orthopedic disorders and led to an increase in the demand for orthobiologics devices and equipment market.

Biodegradable Implants Transforming Orthobiologics And Trauma Orthopedic Surgeries
Biodegradable implants are increasingly being used in orthobiologics treatment and trauma orthopedic surgeries. Biodegradable implants are used to replace a missing biological structure, support a damaged biological structure, and enhance the existing bone structure. Biodegradable products such as re-absorbable polymers composed of polyglycolic acid and polylactic acid manufactured in the form of plates, screws, and pins are replacing traditional devices like plates and screws which are more expensive. Surgeons are preferring biodegradable implants to replace conventional implants, as biodegradable implants can be engineered to provide temporary support for bone fractures, can degrade at a rate matching new tissue formation, eliminate the need for the second surgery, and are highly useful in fracture fixation in children with less implant-related infections. For instance, Stryker Corp. offers orthobiologics such as bone repair biodegradable products that are used in bone regeneration and bone healing, soft tissue regeneration, and muscle connection to bone

The orthobiologics devices and equipment market covered in this report is segmented -

1) By Product Type: Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cell Therapy, Plasma-Rich Protein, Viscosupplementation, Bone Morphogenetic Protein, Synthetic Orthobiologics
2) By Application: Osteoarthritis and Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications, Spinal Fusion, Trauma Repair, Reconstructive Surgery
3) By End Use: Hospitals, Orthopedic Clinics, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=2568&type=discount

Major companies operating in the orthobiologics devices and equipment market report are BONESUPPORT AB, Sanofi SA, Medtronic plc, Kuros Biosciences Ltd., Stryker Corporation, Baxter International Inc., DePuy Synthes, Braun Melsungen AG, Zimmer Biomet Holdings Inc., Terumo BCT Inc., Terumo Corporation, Smith & Nephew plc, Arthrex Inc., Enovis Corp., Integra Lifesciences Holding Corporation, NuVasive Inc., Globus Medical Inc., Wright Medical Group NV, Bioventus LLC, Orthofix Medical Inc., Pioneer Surgical Technology Inc., RTI Surgical Inc., SeaSpine Holdings Corporation, Xtant Medical Holdings Inc., Acumed LLC, Bone Biologics Corp., Osiris Therapeutics Inc., K2M Group Holdings Inc., BSN medical Pvt. Ltd.

Contents of the report:
1. Executive Summary
2. Orthobiologics Devices And Equipment Market Report Structure
3. Orthobiologics Devices And Equipment Market Trends And Strategies
4. Orthobiologics Devices And Equipment Market - Macro Economic Scenario
5. Orthobiologics Devices And Equipment Market Size And Growth
…..
27. Orthobiologics Devices And Equipment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/orthobiologics-devices-and-equipment-global-market-report

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.